Lanthanide-Based Protease Activity Sensors for Time-Resolved Fluorescence Measurements

Luminescent Ln(III)-Metallopeptide Sensors for Monitoring Pseudomonas aeruginosa Elastase B Activity in Complex Biological Media

The detection and monitoring of Pseudomonas aeruginosa and its virulence factors, such as the LasB protease, are crucial for managing bacterial infections. Traditional fluorescent sensors for this protease face limitations in bacterial cultures due to interference from pigments like pyoverdine secreted by this opportunistic pathogen. We report here a Ln(III)-metallopeptide that combines a DO3A-Ln(III) complex and a sensitizing unit via a short peptide sequence as a simple, tunable, and selective probe for detecting P. aeruginosa's LasB. The probe's luminescence switches off in the presence of P. aeruginosa's secretome due to LasB cleavage but remains stable in other bacterial environments, such as non-LasB-secreting P. aeruginosa strains or E. coli cultures. It also resists degradation by other proteases, like human leukocyte elastase and trypsin, and remains stable in the presence of bioanalytes related to P. aeruginosa infections, such as glutathione, H2O2, and pyocyanin, and in complex media like FBS. Importantly, time-gated experiments completely remove the background fluorescence of P. aeruginosa pigments, thus demonstrating the potential of the developed Ln(III)-metallopeptide for real-time monitoring of LasB activity in bacterial cultures.

Boosting the sensitivity with time-gated luminescence thermometry using a nanosized molecular cluster aggregate

Luminescence thermometry with trivalent lanthanide ions is a promising avenue for contactless temperature probing. The area has been growing exponentially for the last two decades, and its viability has been successfully demonstrated in various research domains. However, moving from laboratory equipment to real-life applications remains a challenging task. One of the reasons is the possibility of a background luminescence from the probing device or probed environment. To tackle this issue, we elegantly incorporate a rarely explored thermometric approach called time-gated luminescence thermometry (TGLT). Furthermore, we demonstrate an enhanced relative sensitivity through this innovative approach and a path to move toward practical application.

Time-Resolved Luminescent Sensing and Imaging for Enzyme Catalytic Activity Based on Responsive Probes

Enzymes, as a kind of biomacromolecules, play an important role in many physiological processes and relate directly to various diseases. Developing an efficient detection method for enzyme activity is important to achieve early diagnosis of enzyme-relevant diseases and high throughput screening of potential enzyme-relevant drugs. Time-resolved luminescence assay provide a high accuracy and signal-to-noise ratios detection methods for enzyme activity, which has been widely used in high throughput screening of enzyme-relevant drugs and diagnosis of enzyme-relevant diseases. Inspired by these advantages, various responsive probes based on metal complexes and metal-free organic compounds have been developed for time-resolved bioimaging and biosensing of enzyme activity owing to their long luminescence lifetimes, high quantum yields and photostability. In this review, we comprehensively reviewed metal complex- and metal-free organic compound-based responsive probes applied to detect enzyme activity through time-resolved imaging, including their design strategies and sensing principles. Current challenges and future prospects in this rapidly growing field are also discussed.

A facile turn-on chemiluminescence probe for sensitive imaging on aminopeptidase N activity

Aminopeptidase N, as a target for drug discovery, shows remarkable relationship with many diseases, especially liver injury and cancer. Herein, we explored a chemiluminescence (CL) probe for sensing APN by tethering APN-specific substrate group to the ortho-acrylated phenoxy-dioxetane scaffold. In this manner, two CL probes (APN-CL and BAPN-CL) were designed with non-capped leucine and butoxy-carbonyl capped leucine as the protecting group to preserve the chemiexcitation energy. The uncovered leucine was demonstrated to be essential for detection of APN activity by comparing the CL intensity of two CL probes. Probe APN-CL was turned on upon APN cleavage, resulting in a high chemiluminescent emission, while the chemiexcitation energy of probe BAPN-CL was still restrained even with the high-level APN. The result was elucidated by molecular docking simulation in further. Probe APN-CL exhibited fast response and high sensitivity with a detection limit of 0.068 U/L, and an excellent specificity for the discrimination of APN from biological ions, small molecules and other proteases commonly found in living system. By virtue of good stability and cell viability, probe APN-CL imaged abnormal level of APN in tumor cells and tumor-bearing mice. Moreover, this probe APN-CL could be easily used to evaluate APN inhibitors and APN level in plasma samples from 20 patients. Overall, as a facile and cost-effective probe, APN-CL will be a promising alternative in the early diagnosis of pathologies and cost-effective screening on inhibitors.

Luminescent Lifetime Regulation of Lanthanide-Doped Nanoparticles for Biosensing

Lanthanide-doped nanoparticles possess numerous advantages including tunable luminescence emission, narrow peak width and excellent optical and thermal stability, especially concerning the long lifetime from microseconds to milliseconds. Differing from other shorter-lifetime fluorescent nanomaterials, the long lifetime of lanthanide-doped nanomaterials is independent with background fluorescence interference and biological tissue depth. This review presents the recent advances in approaches to regulating the lifetime and applications of bioimaging and biodetection. We begin with the introduction of the strategies for regulating the lifetime by modulating the core-shell structure, adjusting the concentration of sensitizer and emitter, changing energy transfer channel, establishing a fluorescence resonance energy transfer pathway and changing temperature. We then summarize the applications of these nanoparticles in biosensing, including ion and molecule detecting, DNA and protease detection, cell labeling, organ imaging and thermal and pH sensing. Finally, the prospects and challenges of the lanthanide lifetime regulation for fundamental research and practical applications are also discussed.

Highly Selective and Sensitive Chemiluminescent Probe for Leucine Aminopeptidase Detection in Vitro, in Vivo and in human Liver Cancer Tissue

Leucine aminopeptidase (LAP) is involved in tumor cell proliferation, invasion, and angiogenesis, and is a well-known tumor marker. In recent years, chemiluminescence has been widely used in the field of biological imaging, due to it resulting in a high sensitivity and excellent signal-to-noise ratio. Here, we report the design, synthesis, and evaluation of the first LAP-activated chemiluminescent probe for LAP detection and imaging. The probe initially had no chemiluminescence but produced an extremely strong chemiluminescence after the release of the dioxetane intermediate in the presence of LAP. The probe had high selectivity over other proteases and higher signal-to-noise ratios than commercial fluorophores. Real-time imaging results indicated that the chemiluminescence was remarkably enhanced at the mice tumor site after the probe was injected. Furthermore, the chemiluminescence of this probe in the cancerous tissues of patients was obviously improved compared to that of normal tissues. Taken together, this study has developed the first LAP-activable chemiluminescent probe, which could be potentially used in protein detection, disease diagnosis, and drug development.

The first chemiluminescent probe for the detection of LAP is described. It shows a highly selective, sensitive and rapid chemiluminescence response for the detection of LAP in vitro and in vivo, and enables the differentiation of liver cancer.

A diketopyrrolopyrrole-based ratiometric fluorescent probe for endogenous leucine aminopeptidase detecting and imaging with specific phototoxicity in tumor cells

Leucine aminopeptidase (LAP) is a vital proteolytic enzyme, and its overexpression is often associated with many physiological diseases, such as liver dysfunction and breast cancer. Therefore, the accurate measurement of LAP concentrations in cells is critical for the diagnosis and prevention of related diseases. Herein, a new ratiometric fluorescent probe, DPP-Leu, based on diketopyrrolopyrrole (DPP) was designed and synthesized for LAP detection based on the specific enzymatic cleavage of the N-terminal leucine residue. The fluorescence intensity ratio of DPP-Leu (I₅₄₈/I₆₅₁) showed a remarkable change in the presence of LAP, with a limit of detection of 0.011 U L^-1, and DPP-Leu was successfully applied to detect LAP in fetal bovine serum (FBS) and artificial urine. Cell imaging experiments revealed that DPP-Leu could target mitochondria and distinguish tumor cells with high LAP content from normal cells. Importantly, benefiting from the structural transformation of DPP-Leu to the photosensitizer 4 under LAP catalysis, the probe could kill tumor cells under light irradiation without damaging normal cells.

Luminescent Sm(III) complex bearing dynamic imine bonds as a multi-responsive fluorescent sensor for F- and PO43- anions together with Zn2+ cation in water samples

We have designed and synthesized a new luminescent mononuclear samarium (III) complex Sm-2_h based on the [1 + 1] Schiff-base macrocycle H₂L2_h, derived from the cyclocondensation reaction between dialdehyde and diamine precursors, and its exact architecture is determined to be [Sm(HL2_h) (NO₃)₂]. The sensing ability of complex Sm-2_h is carefully evaluated for various common inorganic ions in solution. It is shown that complex Sm-2_h is a multi-responsive fluorimetric sensor with high selectivity for F^- and PO₄^3- anions together with Zn²⁺ cation. The sensing process is rapid within 60 s for F^- and PO₄^3- ions and 300 s for Zn²⁺ ion. Further detailed responsive investigations suggest that its sensing behavior has excellent linear relationship between the fluorescence intensity (or absorption value) and ion concentration. The limit of detection (LOD) for sensing F^-, PO₄^3- and Zn²⁺ ions are as low as 2.61 μM (2.94 μM), 1.92 μM (1.64 μM) and 5.67 μM (3.53 μM), respectively, verified by fluorimetric (or colorimetric) titration experiments. ESI mass spectra prove that these efficient detections originate from the structure collapse of sensor Sm-2_h because of the ion-induced imine bond breakage. Moreover, sensor Sm-2_h shows excellent sensing performances for F^-, PO₄^3- and Zn²⁺ ions in real water samples, and we also have developed a convenient method to detect these three ions by use of the sensor impregnated test paper strips, providing rapid and distinguishable fluorimetric color changes. Therefore, the macrocyclic Sm(III) complex Sm-2_h could be regarded as a valuable candidate for monitoring F^-, PO₄^3- and Zn²⁺ ions in practical applications.

Human serum albumin-mediated recognition of soluble amyloid-β peptides using a time-resolved luminescent probe in plasma

A terbium(iii) complex can recognize soluble Aβ in plasma through HSA-mediated co-assembly, which can not only circumvent the interference of HSA, but also benefit Aβ enrichment with amplified time-resolved luminescence enhancement.

The Marriage of Protein and Lanthanide: Unveiling a Time-Resolved Fluorescence Sensor Array Regulated by pH toward High-Throughput Assay of Metal Ions in Biofluids

A protein/lanthanide complex (BSA/Tb³⁺)-based sensor array in two different pH buffers has been designed for high-throughput recognition and time-resolved fluorescence (TRF) detection of metal ions in biofluids. BSA, which acted as an antenna ligand, can sensitize the fluorescence of Tb³⁺ (i.e., antenna effect), while the presence of metal ions would lead to the corresponding conformational change of BSA for altering the antenna effect accompanied by a substantial TRF performance of Tb³⁺. This principle has also been fully proved by both experimental characterizations and coarse-grained molecular dynamics (CG-MD) studies. By using Tris-HCl buffer with different pHs (at 7.4 and 8.5), 17 metal ions have been well-distinguished by using our proposed BSA/Tb³⁺ sensor array. Moreover, the sensor array has the potential to discriminate different concentrations of the same metal ions and a mixture of metal ions. Remarkably, the detection of metal ions in biofluids can be realized by utilizing the presented sensor array, verifying its practical applications. The platform avoids the synthesis of multiplex sensing receptors, providing a new method for the construction of convenient and feasible lanthanide complex-based TRF sensing arrays.

Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb3+ Complex

Adenosine deaminase (ADA), which catalyzes the irreversible deamination of adenosine to inosine, is related to various human diseases such as tuberculous peritonitis and leukemia. Therefore, the method used to detect ADA activity and screen the effectiveness of various inhibitor candidates has important implications for the diagnosis treatment for various human diseases. A simple and rapid assay method for ADA, based on the enzymatic formation of a luminescent lanthanide complex, is proposed in this study. Inosine, an enzymatic product of ADA with stronger sensitization efficiency for Tb³⁺ than adenosine, produced a strong luminescence by forming an inosine-Tb³⁺ complex, and it enabled the direct monitoring of ADA activity in real-time. By introducing only Tb³⁺ to adenosine and ADA in the buffer, the enhancement of luminescence enabled the detection of a low concentration of ADA (detection limit 1.6 U/L). Moreover, this method could accurately determine the inhibition efficiency (IC₅₀) of the known ADA inhibitor, erhythro-9-(2-hydroxy-3-nonyl)adenine (EHNA), and the inhibition of ADA could be confirmed by the naked eye. Considering its simplicity, this assay could be extended to the high-throughput screening of various ADA inhibitor candidates.

A series of two-dimensional lanthanide coordination polymers: synthesis, structures, magnetism and selective luminescence detection for heavy metal ions and toxic solvents

A series of two-dimensional (2D) coordination polymers (CPs), namely poly[[bis(μ-acetato)diaqua(μ₆-biphenyl-3,3',5,5'-tetracarboxylato)bis(N,N-dimethylacetamide)digadolinium(III)] N,N-dimethylacetamide monosolvate], {[Gd₂(C₁₆H₆O₈)(C₂H₃O₂)₂(C₄H₉NO)₂(H₂O)₂]·C₄H₉NO}_n (CP1), poly[[bis(μ-acetato)diaqua(μ₆-biphenyl-3,3',5,5'-tetracarboxylato)bis(N,N-dimethylacetamide)didysprosium(III)] N,N-dimethylacetamide monosolvate], {[Dy₂(C₁₆H₆O₈)(C₂H₃O₂)₂(C₄H₉NO)₂(H₂O)₂]·C₄H₉NO}_n (CP2), poly[bis(μ-acetato)diaqua(μ₆-biphenyl-3,3',5,5'-tetracarboxylato)bis(N,N-dimethylacetamide)dineodymium(III)], [Nd₂(C₁₆H₆O₈)(C₂H₃O₂)₂(C₄H₉NO)₂(H₂O)₂]_n (CP3), poly[bis(μ-acetato)diaqua(μ₆-biphenyl-3,3',5,5'-tetracarboxylato)bis(N,N-dimethylacetamide)disamarium(III)], [Sm₂(C₁₆H₆O₈)(C₂H₃O₂)₂(C₄H₉NO)₂(H₂O)₂]_n (CP4), has been synthesized from rigid biphenyl-3,3',5,5'-tetracarboxylic acid under solvothermal conditions. Their structures have been determined by single-crystal X-ray diffraction analyses, elemental analyses, IR spectra, powder X-ray diffraction and thermogravimetric analyses, and CP1-CP4 crystallize in the monoclinic space group P2₁/n. CP1-CP4 are isomorphous and feature similar 2D double layers, which are further extended via interlayer hydrogen-bonding interactions into a three-dimensional (3D) supramolecular structure. Hydrogen-bonding interactions between N,N-dimethylacetamide molecules and carboxylate O atoms strengthen the packing of the layers. The organic ligands interconnect with metal ions to generate 2D layered structures with a (4,4)-connected net having {4⁴.6²} topology. CP1 has been investigated for its magnetic properties and magnetic susceptibility measurements were carried out in the range 2.0-300 K. The results of the magnetic measurements show weak antiferromagnetic coupling between the Gd^III ions in CP1. Moreover, the strong luminescence of CP2 and CP4 can be selectively quenched by the Fe³⁺ ion and toxic solvents (e.g. acetone).

Detection of leucine aminopeptidase activity in serum using surface-enhanced Raman spectroscopy

A specific reaction-based SERS approach was developed for the selective and sensitive detection of leucine aminopeptidase activity in serum.

Rational design of time-resolved turn-on fluorescence sensors: exploiting delayed fluorescence for hydrogen peroxide sensing

Weakly emissive phosphine compounds, which contain a carbazolyl donor-triarylboryl acceptor luminophore, become strongly delayed fluorescent upon changes to their oxide forms. Time-gated acquisition of the fluorescence signals of phosphine in the presence of H2O2 and a competitive fluorescence dye allow for detection of H2O2 with elimination of short-lived fluorescence noise.

Application of lanthanide luminescence in probing enzyme activity

Enzymes play critical roles in the regulation of cellular function and are implicated in numerous disease conditions. Reliable and practicable assays are required to study enzyme activity, to facilitate the discovery of inhibitors and activators of enzymes related to disease. In recent years, a variety of enzyme assays have been devised that utilise luminescent lanthanide(iii) complexes, taking advantage of their high detection sensitivities, long luminescence lifetimes, and line-like emission spectra that permit ratiometric and time-resolved analyses. In this Feature article, we focus on recent progress in the development of enzyme activity assays based on lanthanide(iii) luminescence, covering a variety of strategies including Ln(iii)-labelled antibodies and proteins, Ln(iii) ion encapsulation within defined peptide sequences, reactivity-based Ln(iii) probes, and discrete Ln(iii) complexes. Emerging approaches for monitoring enzyme activity are discussed, including the use of anion responsive lanthanide(iii) complexes, capable of molecular recognition and luminescence signalling of polyphosphate anions.

Recent progresses in small-molecule enzymatic fluorescent probes for cancer imaging

An overview of recent advances in small-molecule enzymatic fluorescent probes for cancer imaging, including design strategies and cancer imaging applications.

Self-Assembled Tb3+ Complex Probe for Quantitative Analysis of ATP during Its Enzymatic Hydrolysis via Time-Resolved Luminescence in Vitro and in Vivo

To more accurately assess the pathways of biological systems, a probe is needed that may respond selectively to adenosine triphosphate (ATP) for both in vitro and in vivo detection modes. We have developed a luminescence probe that can provide real-time information on the extent of ATP, ADP, and AMP by virtue of the luminescence and luminescence lifetime observed from a supramolecular polymer based on a C₃ symmetrical terpyridine complex with Tb³⁺ (S1-Tb). The probe shows remarkable selective luminescence enhancement in the presence of ATP compared to other phosphate-displaying nucleotides including adenosine diphosphate (ADP), adenosine monophosphate (AMP), guanosine triphosphate (GTP), thymidine triphosphate (TTP), H₂PO₄^- (Pi), and pyrophosphate (PPi). In addition, the time-resolved luminescence lifetime and luminescence spectrum of S1-Tb could facilitate the quantitative measurement of the exact amount of ATP and similarly ADP and AMP within living cells. The time-resolved luminescence lifetime of S1-Tb could also be used to quantitatively monitor the amount of ATP, ADP, and AMP in vitro following the enzymatic hydrolysis of ATP. The long luminescence lifetime, which was observed into the millisecond range, makes this S1-Tb-based probe particularly attractive for monitoring biological ATP levels in vivo, because any short lifetime background fluorescence arising from the complex molecular environment may be easily eliminated.

Visualization of Fluoride Ions In Vivo Using a Gadolinium(III)-Coumarin Complex-Based Fluorescence/MRI Dual-Modal Probe

A new Gadolinium(III)-coumarin complex, DO3A-Gd-CA, was designed and prepared as a dual-modal probe for simultaneous fluorescence and relaxivity responses to fluoride ions (F-) in aqueous media and mice. DO3A-Gd-CA was designed by using Gd(III) center as an MRI signal output unit and fluoride binding site, and the 4-(diethylamino)-coumarin-3-carboxylic acid (CA) as a fluorescence reporter. Upon the addition of fluoride ions to the solution of DO3A-Gd-CA, the liberation of the coordinated CA ligand led to a 5.7-fold fluorescence enhancement and a 75% increase in the longitudinal relaxivity (r₁). The fluorescent detection limit for fluoride ions was determined to be 8 μM based on a 3σ/slope. The desirable features of the proposed DO3A-Gd-CA, such as high sensitivity and specificity, reliability at physiological pH and low cytotoxicity enable its application in visualization of fluoride ion in mice. The successful in vivo imaging indicates that DO3A-Gd-CA could be potentially used in biomedical diagnosis fields.

In Situ Ratiometric Quantitative Tracing of Intracellular Leucine Aminopeptidase Activity via an Activatable Near-Infrared Fluorescent Probe

Leucine aminopeptidase (LAP), one of the important proteolytic enzymes, is intertwined with the progress of many pathological disorders as a well-defined biomarker. To explore fluorescent aminopeptidase probe for quantitative detection of LAP distribution and dynamic changes, herein we report a LAP-targeting near-infrared (NIR) fluorescent probe (DCM-Leu) for ratiometric quantitative trapping of LAP activity in different kinds of living cells. DCM-Leu is composed of a NIR-emitting fluorophore (DCM) as a reporter and l-leucine as a triggered moiety, which are linked together by an amide bond specific for LAP cleavage. High contrast on the ratiometric NIR fluorescence signal can be achieved in response to LAP activity, thus enabling quantification of endogenous LAP with "build-in calibration" as well as minimal background interference. Its ratiometric NIR signal can be blocked in a dose-dependent manner by bestatin, an LAP inhibitor, indicating that the alteration of endogenous LAP activity results in these obviously fluorescent signal responses. It is worth noting that DCM-Leu features striking characteristics such as a large Stokes shift (∼205 nm), superior selectivity, and strong photostability responding to LAP. Impressively, not only did we successfully exemplify DCM-Leu in situ ratiometric trapping and quantification of endogenous LAP activity in various types of living cells, but also, with the aid of three-dimensional confocal imaging, the intracellular LAP distribution is clearly observed from different perspectives for the first time, owing to the high signal-to-noise of ratiometric NIR fluorescent response. Collectively, these results demonstrate preclinical potential value of DCM-Leu serving as a useful NIR fluorescent probe for early detection of LAP-associated disease and screening inhibitor.

Leucine aminopeptidase may contribute to the intrinsic resistance of cancer cells toward cisplatin as revealed by an ultrasensitive fluorescent probe

Cisplatin, a typical anticancer drug, is often used to treat different cancers, and leucine aminopeptidase (LAP) is known to be widely distributed in organisms from bacteria to humans, including various cancer cells. However, cancer cells display different intrinsic or acquired resistance toward cisplatin, and it is unclear whether intracellular LAP plays a role in the intrinsic drug resistance, mainly due to the lack of a sensitive detection approach for LAP because this enzyme usually exists at trace levels in cancer cells. Herein, by developing an ultrasensitive LAP fluorescent probe (detection limit 0.42 ng mL-1) and combining it with confocal fluorescence imaging, we analyze the concentration change of LAP in cancer cells such as HepG2 and A549 cells under cisplatin treatment. We find that a large increase in the LAP concentration occurs in HepG2 rather than in A549 cells. These different changes are further confirmed by an ELISA kit. A cell viability assay reveals that HepG2 cells with a higher level of LAP have much stronger resistance toward cisplatin than A549 cells, suggesting that LAP may serve as a simple indicator to reflect the relative resistance of different cancer cells. Importantly, inhibiting the expression of LAP with siRNA further decreases cell viability. These findings support that LAP may contribute to the intrinsic resistance of cancer cells toward cisplatin. In addition, the proposed probe may find more uses in studying the cellular LAP function, and improving chemotherapeutic cancer treatment.

Tri- and tetranuclear RuII–GdIII2 and RuII–GdIII3 d–f heterometallic complexes as potential bimodal imaging probes for MRI and optical imaging

Tri- and tetranuclear Ru^II–GdII2 and Ru^II–GdIII3 d–f heterometallic complexes, which function as contrast agents for MRI and as optical probes for fluorescence imaging, are reported. In vitro studies using the HeLa cell lines show that these complexes exhibit anticancer activity.

A gadolinium(iii) complex based dual-modal probe for MRI and fluorescence sensing of fluoride ions in aqueous medium and in vivo

A novel Gd(iii) complex based dual-modal probe, Gd(TTA)₃-DPPZ was designed and assembled for the simultaneous fluoride ion in aqueous media and in vivo.

Fluoride-specific fluorescence/MRI bimodal probe based on a gadolinium(iii)–flavone complex: synthesis, mechanism and bioimaging application in vivo

The present work reports a bimodal probe for the fluorescence and magnetic resonance detection of fluoride ion (F⁻) in aqueous medium andin vivo.

A lysosome targetable luminescent bioprobe based on a europium β-diketonate complex for cellular imaging applications

A unique bright luminescent europium coordination compound with excellent biocompatibility has been developed that serves as a selective bioprobe for particular organelles within the cells.

Synthesis, relaxivity, and in vitro fluorescence imaging studies of a novel d-f heterometallic trinuclear complex as a potential bimodal imaging probe for MRI and optical imaging

A new trinuclear heterometallic Ru(II)-Gd complex of 4-aminopyridine appended DO3A (DO3A = 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane) with 2,2'-bipyridine as ancillary ligands is synthesized and its relaxometry and in vitro fluorescence imaging studies are reported. The complex [Ru(bpy)2{Gd(DOTA-AMpy)(H2O)}2]Cl2 (7) exhibits a "per Gd" longitudinal relaxivity (r1p) of 5.80 and 14.30 mM(-1) s(-1) in aqueous solution and in the presence of HSA, respectively (20 MHz, pH = 7.4, PBS, 37 °C). The complex 7 exhibits an intense (1)MLCT absorption band at 480 nm and luminesces at 595 nm with a luminescence quantum yield of 3.2%. The fluorescence microscopy imaging study of HeLa cells incubated with 7 and stained with ethidium bromide and acridine orange confirms that the cells are viable throughout the imaging experiments and its cytotoxicity against HeLa cells, studied by the MTT assay, demonstrates its use for bioimaging studies. HeLa cell lines treated with the complex 7 and stained with Hoechst-33342 showed marked morphological signs of apoptosis in a dose-dependent manner by inducing changes in cell cycle arrest at the G2/M phase. Furthermore, apoptosis of HeLa cells, studied by the DNA ladder assay, indicates apoptotic cell death lending support for the antitumor activity of 7. A molecular docking study reveals that the complex 7 intercalates into the major groove of the DNA stabilized by hydrogen bonding and it binds with HSA by electrostatic- and hydrogen bonding interactions. The relaxometry, luminescence and fluorescence imaging studies indicate that the Ru(II)-Gd complex 7 has a good cell membrane permeability and could be considered as a potential bimodal imaging probe.

Reversible Switching of Tb(III) Emission by Sensitization from 2,3-Dihydroxynaphthalene in an Isothermally Reversible Ionic Liquid

A reversible room-temperature ionic liquid (ILO) was prepared by the addition of CO2 to an equimolar mixture of hexylamidine (AD) and butylamine (AN). The ILO and AD/AN mixture were cycled repeatedly by alternating the passage of CO2 and N2 gases through the liquid. The ILO was utilized to sensitize very efficiently energy transfer to and emission by Tb(III) ions when 2,3-dihydroxynaphthalene (DHN) was irradiated. The emission was nearly completely quenched in the AD/AN mixture. The process described here is unique in its use of CO2 and N2 to "switch on and off" the emission by a lanthanide ion, Tb(III) in this case. In the corresponding amidinium dithiocarbamate ionic liquid (ILS), no appreciable Tb(III) emission was found due to quenching of the excited singlet state of DHN by thio groups. The ILS was not reconverted to the AD/AN mixture upon adding N2; N2 bubbling did not result in the displacement of CS2.

A novel heterobimetallic Ru(ii)–Gd(iii) complex-based magnetoluminescent agent for MR and luminescence imaging

A novel heterobimetallic ruthenium(II)–gadolinium(III) complex, Ru–Gd, has been developed for luminescence and an vivo T₁-weighted MR imaging agent.

Terbium(iii)-cholate functionalized vesicles as luminescent indicators for the enzymatic conversion of dihydroxynaphthalene diesters

The phosphorescence intensity of unilamellar DOPC vesicles with embedded Tb³⁺-cholate complexes depends on the concentration of dihydroxynaphthalene (DHN) as sensitizer in solution.

Millisecond lifetime imaging with a europium complex using a commercial confocal microscope under one or two-photon excitation

We demonstrate that a commercial confocal microscope can perform time-gated and long lifetime imaging in the μs to ms range under classical one photon or nonlinear two photon excitation.